Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Afya Limited (AFYA) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20‑F and Form 6‑K. This SEC filings page centralizes access to those documents, which provide detailed information on the company’s operations as a medical education group and medical practice solutions provider in Brazil.
Afya’s Form 20‑F annual report contains audited financial statements and extensive narrative disclosures on its three reportable segments: Undergraduate, Continuing Education and Medical Practice Solutions. Investors can review segment definitions, revenue composition, key operational metrics and risk factors related to its physician‑centric ecosystem and Brazilian regulatory environment.
Throughout the year, Afya files multiple Form 6‑K reports. These include unaudited interim condensed consolidated financial statements, press releases announcing quarterly and half‑year financial results, and disclosures on specific corporate events. Examples documented in recent 6‑Ks include new share repurchase programs for Class A common shares, issuance of commercial notes by Afya Participações S.A., repayment of debentures, repurchase and cancellation of Series A perpetual convertible preferred shares, changes to the board of directors, results of the annual general meeting and the engagement of a new independent registered public accounting firm.
For investors analyzing AFYA, these filings are key sources for understanding revenue trends, adjusted EBITDA, net income, capital structure decisions and governance developments. They also provide context on Afya’s medical school seat authorizations and other regulatory milestones in Brazil’s higher education sector.
On Stock Titan, Afya’s SEC filings are updated in line with EDGAR submissions and can be paired with AI‑powered summaries that explain the main points of lengthy documents. Users can quickly identify which filings relate to financial results, capital markets transactions, governance changes or other material events, and then drill down into the full text when deeper analysis is required.
Afya Limited filed a Form S-8 to register additional Class A common shares for its equity incentive plans. The filing covers 3,393,220 shares authorized for issuance under the Amended and Restated Stock Option Plan and 987,016 shares authorized for issuance under the Restricted Stock Plan.
The registration incorporates by reference Afya’s Annual Report on Form 20-F for the year ended December 31, 2024 and subsequent Exchange Act reports. The shares have a par value of $0.00005 per share. This administrative filing expands the pool of shares available for future grants under the company’s employee equity plans.
Afya Limited filed a Form 6-K reporting an operational update. The company announced a medical seats increase at AFYA Faculdade de Ciências Médicas Bragança, as noted in Exhibit 99.1.
The report was signed by Chief Executive Officer Virgilio Deloy Capobianco Gibbon on November 7, 2025.
Afya Limited, a Brazil-based foreign private issuer, submitted a Form 6-K for August 2025. The filing mainly serves to furnish an exhibit titled "Afya Limited Announces a New Share Repurchase Program," indicating the company has authorized a new program to buy back its own shares. The report is signed on behalf of Afya by its Chief Executive Officer, Virgilio Deloy Capobianco Gibbon.
FAQ
What is the current stock price of Afya (AFYA)?
What is the market cap of Afya (AFYA)?
